Literature DB >> 23292232

Involvement of N-cadherin in the protective effect of glial cell line-derived neurotrophic factor on dopaminergic neuron damage.

Tao Zuo1, Jane Yuxia Qin, Jing Chen, Zixiao Shi, Meiying Liu, Xiuxian Gao, Dianshuai Gao.   

Abstract

The aim of this study was to further confirm that glial cell line-derived neurotrophic factor (GDNF) exerts a neuro-protective effect on dopaminergic neurons (DAs) and to investigate the protective mechanism. Cadherins are calcium-dependent adhesion proteins, and N-cadherins are found in neurons. Our study attempted to ascertain whether GDNF activates the PI3K/Akt signaling pathway through the mediation of N-cadherin to confer a protective effect on DAs. Flow cytometry and Hoechst 33258 staining results indicated that the apoptosis rate of damaged neurocytes increased following interference of N-cadherin expression. Immunoblotting results demonstrated that the amount of phosphorylated Akt (p-Akt) in the cytoplasm decreased, while the total Akt quantity remained unchanged following interference of N-cadherin expression. The immunohistochemical staining results demonstrated that the levels of total N-cadherin, phosphorylated N-cadherin (Tyr860) and p-Akt decreased; however, the amount of total Akt remained unchanged. In addition, we also demonstrated that Tyr860 and p-Akt levels were reduced in a GDNF dose-dependent manner with the phosphorylation level peaking at GDNF dose of 50 ng/ml (in vitro) and 50 ng/4 µl (in vivo), and also in a time-dependent manner with the phosphorylation level peaking at 15 min (in vitro) and 30 min (in vivo). Statistical analysis also showed that changes in the phosphorylation levels of Tyr860 and p-Akt demonstrated a positive correlation. Collectively, GDNF activates the PI3K/Akt pathway via N-cadherin to protect DAs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23292232     DOI: 10.3892/ijmm.2013.1226

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  11 in total

1.  N-cadherin is a novel ERα anchor that protects against 6-OHDA damage to dopaminergic cells.

Authors:  Meng Wang; Feng Li; Zixiao Shi; Yaping Liu; Xiaozhou Wang; Li Li; Dianshuai Gao
Journal:  Cell Mol Neurobiol       Date:  2013-11-20       Impact factor: 5.046

2.  iPSC-Derived neural stem cells act via kinase inhibition to exert neuroprotective effects in spinal muscular atrophy with respiratory distress type 1.

Authors:  Chiara Simone; Monica Nizzardo; Federica Rizzo; Margherita Ruggieri; Giulietta Riboldi; Sabrina Salani; Monica Bucchia; Nereo Bresolin; Giacomo P Comi; Stefania Corti
Journal:  Stem Cell Reports       Date:  2014-07-04       Impact factor: 7.765

3.  Ret is essential to mediate GDNF's neuroprotective and neuroregenerative effect in a Parkinson disease mouse model.

Authors:  Anja Drinkut; Karsten Tillack; Durga P Meka; Jorg B Schulz; Sebastian Kügler; Edgar R Kramer
Journal:  Cell Death Dis       Date:  2016-09-08       Impact factor: 8.469

4.  Neuropilin-1 is a glial cell line-derived neurotrophic factor receptor in glioblastoma.

Authors:  Shen Sun; Yu Lei; Qi Li; Yue Wu; Lin Zhang; Pei-Pei Mu; Guang-Quan Ji; Chuan-Xi Tang; Yu-Qian Wang; Jian Gao; Jin Gao; Li Li; Lang Zhuo; Yun-Qing Li; Dian-Shuai Gao
Journal:  Oncotarget       Date:  2017-06-27

5.  Precursor N-cadherin mediates glial cell line-derived neurotrophic factor-promoted human malignant glioma.

Authors:  Ye Xiong; Liyun Liu; Shuang Zhu; Baole Zhang; Yuxia Qin; Ruiqin Yao; Hao Zhou; Dian Shuai Gao
Journal:  Oncotarget       Date:  2017-04-11

Review 6.  Neural Stem Cell Transplantation for Neurodegenerative Diseases.

Authors:  Roberta De Gioia; Fabio Biella; Gaia Citterio; Federica Rizzo; Elena Abati; Monica Nizzardo; Nereo Bresolin; Giacomo Pietro Comi; Stefania Corti
Journal:  Int J Mol Sci       Date:  2020-04-28       Impact factor: 5.923

7.  Secretome of Undifferentiated Neural Progenitor Cells Induces Histological and Motor Improvements in a Rat Model of Parkinson's Disease.

Authors:  Bárbara Mendes-Pinheiro; Fábio G Teixeira; Sandra I Anjo; Bruno Manadas; Leo A Behie; António J Salgado
Journal:  Stem Cells Transl Med       Date:  2018-09-20       Impact factor: 6.940

8.  Preclinical Comparison of Stem Cells Secretome and Levodopa Application in a 6-Hydroxydopamine Rat Model of Parkinson's Disease.

Authors:  Fábio G Teixeira; Helena Vilaça-Faria; Ana V Domingues; Jonas Campos; António J Salgado
Journal:  Cells       Date:  2020-01-28       Impact factor: 6.600

Review 9.  p38 MAPK and PI3K/AKT Signalling Cascades inParkinson's Disease.

Authors:  Saurabh Kumar Jha; Niraj Kumar Jha; Rohan Kar; Rashmi K Ambasta; Pravir Kumar
Journal:  Int J Mol Cell Med       Date:  2015

10.  e-Cadherin in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinson Disease.

Authors:  Samuela Cataldi; Michela Codini; Stéphane Hunot; François-Pierre Légeron; Ivana Ferri; Paola Siccu; Angelo Sidoni; Francesco Saverio Ambesi-Impiombato; Tommaso Beccari; Francesco Curcio; Elisabetta Albi
Journal:  Mediators Inflamm       Date:  2016-04-17       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.